BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mejia-Vilet JM, Gómez-Ruiz IA, Cruz C, Méndez-Pérez RA, Comunidad-Bonilla RA, Uribe-Uribe NO, Nuñez-Alvarez CA, Morales-Buenrostro LE. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis. Clin Rheumatol 2021;40:2233-42. [PMID: 33170371 DOI: 10.1007/s10067-020-05499-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Morell M, Pérez-Cózar F, Marañón C. Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis. Int J Mol Sci 2021;22:7143. [PMID: 34281193 DOI: 10.3390/ijms22137143] [Reference Citation Analysis]
2 Massicotte-Azarniouch D, Kotzen E, Todd S, Hu Y, Hogan SL, Jain K. Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis. Lupus 2022;:9612033221106301. [PMID: 35650019 DOI: 10.1177/09612033221106301] [Reference Citation Analysis]
3 González MA, Barrera-Chacón R, Peña FJ, Fernández-Cotrina J, Robles NR, Pérez-Merino EM, Martín-Cano FE, Duque FJ. Urinary proteome of dogs with renal disease secondary to leishmaniosis. Res Vet Sci 2022;149:108-18. [PMID: 35777279 DOI: 10.1016/j.rvsc.2022.04.013] [Reference Citation Analysis]
4 Ding Y, Yu X, Wu L, Tan Y, Qu Z, Yu F. The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients. Front Immunol 2021;12:654652. [PMID: 34276649 DOI: 10.3389/fimmu.2021.654652] [Reference Citation Analysis]